Role of Litigation in Defining Drug Risks_JAMA / BMJ
Documents uncovered during the course of litigation shed light on real risks of drug-induced harm that would not otherwise be known.
Documents uncovered during the course of litigation shed light on real risks of drug-induced harm that would not otherwise be known.
The authors argue that recommendations for the expanded use of statins to stave off cardiovascular disease are NOT supported by the evidence.
The Baltimore Sun reports (below) that in a paper scheduled for publication in the journal Epidemiology and Infection, a Harvard University-led team proposes that a vitamin D deficiency caused by inadequate winter sun exposure may predispose people to infection.
Selling Sickness: Pharma Industry Turning Us All Into Patients Mon, 12 Sep 2005 Related Link: Selling Sickness Prologue Selling Sickness: How the World’s Pharmaceutical Companies Are Turning Us All Into Patients, by Ray Moynihan, an international health journalist, and Alan Cassels, a pharmaceutical policy researcher, is likely to become a…
Vaccinated Doctors Could Hurt Patients_JAMA Tue, 25 Mar 2003 A startling report in the Journal of the American Medical Association (JAMA) raises serious concerns about the risks posed by the smallpox vaccine: After examining the data on 2.4 million patients discharged from New York hospitals in 2001, researchers found that…
Protecting People with Mental Disabilities and Impairments against Biomedical Research Abuse[*] By John H. Noble, Jr., Ph.D, The Catholic University of America, Washington, DC, USA Vera Hassner Sharav, MLS, Alliance for Human Research Protection, New York, USA People with mental disabilities and impairments historically have been targeted by biomedical researchers…
$95 billion a year spent on medical research in US – JAMA Fri, 23 Sep 2005 A special issue of the Journal of the American Medical Association, JAMA, focuses on medical research spending and findings. A study that examined US spending for medical research—$95 billion approaching $100 billion–57% is spent…
Cognititve Therapy Halves Risk of Second Suicide Attempt – JAMA Tue, 6 Sep 2005 A study tested the effect of cognitive therapy in reducing the risk of a second suicide attempt by following 120 people who had attempted suicide. They were followed for 18 months–far longer than drug trials. According…
The Evidence base: rock of certainty or shifting sands? – BMJ Wed, 5 May 2004 Dr. John Dewhurst, has written an extraordinary article from his first-hand experience as a pharmaceutical company physician who discovered the disparity that exists between the claimed and actual evidence of drug effectiveness–and the reality-based severe,…
Psychiatric Drugs Pushing Children to Crisis Units_Tampa Tribune Tue, 15 Apr 2003 A report in the Tampa Tribune following its five month investigation, shows how misprescribing of psychiatric drugs for children can precipitate life-threatening tragedies. The report describes a 9 year old child’s descent into suicidal violence after she had…
Auditing Standards in Accounting and Medicine Wed, 4 Jun 2003 “Those financial calamities made it brutally clear that the present audit standards and practices are severely deficient, since the failing enterprises had managed to issue misleading financial reports that nevertheless were attested to and blessed at the time by “see…
Infomail 2005 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Subscribe to the AHRP infomail list Dec 16: Drugs, Devices & Doctors – NYT Paul Krugman Dec 11: Scientific Fraud & Corruption on Both sides of Atlantic: Merck / Proctor & Gamble Dec 11: Gov Accountability…